XGX Pharma ApS: Financial statements 2018
CVR: 32289290
XGX Pharma ApS (CVR 32289290) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,574,797 and a net result of DKK 26,878 compared with DKK -189,057 the year before. That is an increase of 1,408% compared with the year before. Equity amounted to DKK 59,347. The solvency ratio was 1.7%. The company had 1 employee in the financial year.
- Gross Profit
- 1,574,797 kr.
- Profit/Loss
- 26,878 kr.
- Equity
- 59,347 kr.
- Total Assets
- 3,486,915 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1.6 mio. | 27 t. | 59 t. | 1 |
| 2017 | - | 104 t. | -189 t. | 32 t. | - |
| 2016 | - | 307 t. | 272 t. | 92 t. | - |
| 2015 | - | -33 t. | -35 t. | -180 t. | - |
| 2014 | - | - | -14 t. | -145 t. | - |
Keep an eye on XGX Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
As of November 1, 2018, Mohammad Sohail Asghar has joined the board of directors of XGX Pharma ApS.
As of November 1, 2018, Per Ludvigsen has joined the board of directors of XGX Pharma ApS.
As of November 1, 2018, Jens-Nikolaj Schøier has joined the board of directors of XGX Pharma ApS.
XGX Pharma ApS has published its annual report for 2017. Gross profit came to DKK 104,432, and the net result was DKK -189,057.
About XGX Pharma ApS
XGX Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens-Nikolaj Schøier. The company is owned by Unimedic Pharma AB. The company has 2 employees. In 2025, the company reported a gross profit of DKK 32,338,381 and a net result of DKK 16,074,119 compared with DKK 4,453,433 the year before. Equity amounted to DKK 30,787,180.
